Heart failure & cardiomyopathiesCross-sectional study

Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure

JAMA CardiolPublished

  • Cross-sectional study
  • prospective
  • multicenter
  • Enrolled May 2019 to June 2024

Authors' conclusion

In this cross-sectional study, ATTR-CA was an important cause of HF in older Black individuals with HF, particularly in men older than 75 years. Approximately half of V142I carriers with HF had ATTR-CA, while 55.8% of all ATTR-CA cases had normal TTR genotype.

Study context

Population
Self-identified Black or Caribbean Hispanic individuals older than 60 years with heart failure (HF), several major US cities
Participants
646 participants
Outcome
Prevalence of ATTR-CA (radionuclide imaging) and proportions attributable to ATTRwt-CA or ATTRv-CA

Main finding

As reported in the abstract

Overall prevalence of ATTR-CA

Overall prevalence of ATTR-CA

6.66% (95% CI 4.73%-8.58%)

ATTRwt-CA among ATTR-CA cases

24 (55.8%)

ATTRv-CA owing to V142I among ATTR-CA cases

19 (44.2%)

Observational data: associations, not effects.

Further findings

OutcomeValuesP value
Prevalence of ATTR-CA by sex (subgroup)Men 8.15% (95% CI 5.15%–11.15%) · Women 5.20% (95% CI 2.79%–7.61%)P = 0.13
Prevalence of ATTR-CA by ethnicity (subgroup)Black 7.82% (95% CI 5.57%–10.06%) · Hispanic 2.15% (95% CI 0.07%–4.24%)P = 0.004
Prevalence of ATTR-CA in Black participants by age (subgroup)Aged ≤75 years 3.42% (95% CI 1.43%–5.40%) · Older than 75 years 14.04% (95% CI 9.53%–18.54%)P < 0.001

V142I allele

Overall prevalence of V142I allele
5.6%
V142I carriers with ATTRv-CA
19 (52.8%)

Prevalence of ATTR-CA in Black men older than 75 years (subgroup)

Prevalence
17.17% (95% CI 9.74%-24.60%)

Original publication

Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure. JAMA Cardiol. Published 1 October 2025. doi:10.1001/jamacardio.2025.2948

Summarised from the published abstract; every number is checked against it